# Metformin and Simvastatin Use in Bladder Cancer

> **NCT02360618** · PHASE2 · UNKNOWN · sponsor: **London Health Sciences Centre** · enrollment: 44 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Metformin
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT02360618
- **Lead sponsor:** London Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02360618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02360618, "Metformin and Simvastatin Use in Bladder Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02360618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*